Sigmoid sinus wall reconstruction (pulsatile tinnitus): What Does the Evidence Show?

Current evidence

Surgical repair of a defect in the bony wall of the sigmoid sinus — an alternative to stenting for one specific, imaging-confirmed cause of pulsatile tinnitus.

Evidence strength: Limited (2/5) · Tier 3 — experimental/emerging · Evidence independence: Primarily independent.

For PULSATILE tinnitus caused by a sigmoid sinus wall anomaly (dehiscence or diverticulum seen on imaging), a surgeon rebuilds the bony wall between the venous sinus and the ear, blocking transmission of the blood-flow sound. It treats the same family of vascular causes as venous sinus stenting, from the outside rather than inside the vein.

Did tinnitus loudness improve?

Moderate. Uncontrolled series report elimination of the pulsatile sound in most correctly selected patients (pooled 77.6% complete resolution; 83.8% durable at 5+ years in the longest cohort; ~65% under stricter definitions). Rated moderate, not strong: no controlled data, and outcome definitions vary widely.

Did tinnitus distress improve?

Limited. Distress typically resolves with the sound, but series rarely measure THI/TFI systematically.

Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.

How strong is the evidence?

Uncontrolled surgical case series only (no RCT, no comparative trial vs stenting): pooled complete resolution 77.6% in a systematic review, 97.3% short-term / 83.8% at 5+ years in the longest cohort — but with 9.3% significant complications, 13.5% recurrence, and new intracranial-hypertension diagnoses in 8.6%. Resolution rates drop (to ~65% in one cohort) under stricter outcome definitions. High apparent effect in a narrow, imaging-confirmed subgroup; low certainty by design.

Has the result been independently replicated?

Limited independent. Consistent high resolution rates across several independent surgical centers — but every series is uncontrolled, so what replicates is the case-series pattern, not a controlled effect.

What are the limitations?

• Case series only — no randomized or controlled data
• Outcome definitions vary; stricter criteria give lower success rates (~65%)
• Post-operative intracranial hypertension is a real, under-appreciated risk
• Applies to one imaging-confirmed anatomy, not pulsatile tinnitus generally

What should patients know about safety?

Safety evidence: Limited. Real surgical risks: significant complications in 9.3% of pooled cases; intracranial hypertension/papilledema can emerge after reconstruction (new IIH diagnosed in 8.6% of the long-term cohort; some patients later needed venous stenting); recurrence 13.5%.

Is it available?

Regulatory status: Surgical procedure (no device approval applicable). Standard otologic/neurosurgical techniques; no dedicated device.

Availability: Tertiary otology/neurotology centers after full imaging workup · Europe: Same · Cost (approx.): Surgical-procedure costs; often covered when medically indicated

What the studies found

Related treatments

• Venous sinus stenting (pulsatile tinnitus) — Pulsatile tinnitus is a different disease — and when a venous narrowing is the cause, stenting resolves it…